… state of tau and therefore are candidate targets for therapeutic intervention in AD. … peptides
that accumulate in the brains of patients with Alzheimer's disease (AD). The primacy of APP in …

… for treating Alzheimer’s disease as a new therapeutic intervention. Key words: Alzheimer’s
disease, ginsenoside … Panax ginseng enhances cognitive performance in Alzheimer disease. …

… (n = 1) as therapeutic interventions. Table 2 lists some characteristics of these trials. The
metabolic intermediate OAA listed in this table is being tested by our group in a Phase 1b trial (…

… Moreover, we analyze how these vulnerable points for Aβ-mediated mitochondrial dysfunction
may be distinctive and perhaps complementary therapeutic intervention targets for AD. …

… Alzheimer's Disease (AD) in several epidemiologic investigations. It is now widely accepted
that cerebrovascular disease … and pharmacological therapeutic approaches for AD treatment…

… The inter-relationship between vascular dysfunction and Alzheimer's disease pathology …
Alzheimer's disease and cerebrovascular amyloid angiopathy. We will also discuss therapeutic …

… -inflammatory therapies) have generally failed to prove to be efficacious preventive or therapeutic
… when designing preventive or therapeutic intervention against the dementing disorder. …

The present study posits that Alzheimer’s disorder is a “fast” disease. This is in sharp
contrast to a view, prevailing until now, that Alzheimer’s Disease (AD) is a quintessential “slow” …

… Existing drugs provide only short-term symptomatic benefits, while the development of
effective disease-modifying therapeutic interventions that would prevent, halt, or reverse AD …

… the potential of GLP-1 and analogs as novel therapeutic targets for intervention in Alzheimer's
disease (AD) and potentially other central and peripheral neurodegenerative conditions. …